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ABSTRACT 
Diabetic retinopathy (DR) is the major cause of blindness among the working-age population globally. No systematic 
research has been previously performed to analyze the research published on DR, despite the need for it. This study 
aimed to analyze the scientific production on DR to draw overall roadmap of future research strategic planning in this 
field. A bibliometric method was used to obtain a view on the scientific production about DR by the data extracted from 
the Institute for Scientific Information (ISI). Articles about DR published in 1993–2013 were analyzed to obtain a view of 
the topic’s structure, history, and to document relationships. The trends in the most influential publications and authors 
were analyzed. Most highly cited articles addressed epidemiologic and translational research topics in this field. During 
the past 3 years, there has been a trend toward biomarker discovery and more molecular translational research. Areas 
such as gene therapy and micro-RNAs are also among the recent hot topics. Through analyzing the characteristics of 
papers and the trends in scientific production, we performed the first scientometric report on DR. Most influential 
articles have addressed epidemiology and translational research subjects in this field, which reflects that globally, the 
earlier diagnosis and treatment of this devastating disease still has the highest global priority. 
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INTRODUCTION 
An estimated 382 million people had diabetes in 2013; 
this is expected to rise to 592 million by 2035 (1). 
Diabetic retinopathy (DR), age-related macular 
degeneration (ARMD), glaucoma, and childhood causes 
are the most common causes of low vision in all 
countries (2). Estimates of the prevalence of DR vary by 
study and rates range from 17.6% in a study in India to 
33.2% in a large United States study (3, 4). There were 
126.6 million people with DR worldwide in 2010; this is 
expected to increase to 191.0 million by 2030. The 
number of patients with vision-threatening DR will 
increase from 37.3 million to 56.3 million (5, 6). If a 
diabetic patient does not have retinopathy, studies 
suggest that the risk of developing new retinopathy 
ranges between 5% and 10% annually. Thus, there is an 
urgent need for prompt action. 
Preventing and treating DR are major concerns in this 
field. If fundamental social and political changes are 
available, the prevention of diabetes would be the best 
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approach to prevent DR. Factors which lower the risk of 
visual morbidities and disease progression in diabetic 
patients include optimal blood glucose and blood 
pressure control beside regular ocular examinations and 
prompt laser treatment of macular edema as well as 
proliferative retinopathy. The Wisconsin Epidemiologic 
Study of Diabetic Retinopathy (i.e., WESDR) first 
identified key risk factors for DR such as longer duration 
of diabetes, hyperglycemia, and hypertension (7, 8). 
Based on the finding of this study and other studies, new 
screening strategies need to be developed that detect 
potential vision-threatening retinopathy early in clinical 
and nonclinical settings. Genetic risk factors for diabetes 
and DR should be identified, and the interactions 
between genes and metabolic control should be 
examined; these factors will help in risk stratification and 
in preventing vision loss (9). Therefore, implementing of 
novel, feasible, and sustainable strategies to control the 
growing current of DR is a significant challenge. Part of 
the challenge is the need for global level research 
strategic planning for preventing and treating DR. 
Many clinical reviews and meta-analyses exist on DR, and 
scientometric studies investigating other topics in 
ophthalmology exist; however, quantitative description 
of publications specifically on DR is lacking. Recent 
bibliometric analysis of scientific publications has been 
performed for individual and institutional output 
analysis, and for assessing the scientific advancements 
and motivations of researchers and identifying current 
research directions in a specific field; fund assignments 
and subsequent research designs can be enhanced using 
such data because it will predict how this field will move 
forward (10, 11). Mapping the external and internal 
features of a scientific field by tracing the core 
production or citations, would aid in research that is 
more global strategic planning. Thus, we aimed to 
analyze the scientific productions on DR to define a 
general roadmap for future research strategic planning in 
this field. 
 
MATERIAL AND METHODS 
Data Source 
A descriptive bibliometric study of scientific papers about 
DR was conducted. For this purpose, the ISI Web of 
Science database (available at 
http://www.isiknowledge.com) was used because it is a 
major source for bibliometrics, citations, and other 
academic impact information of scientific articles in 
various branches of sciences. All three resources 
available in the ISI web of science were used for this 
purpose (Science Citation Index Expanded; Social 




For the best keywords, we created a list from the 
Medical Subject Headings (MeSH), which is provided by 
the National Library of Medicine (NLM, Bethesda, MD, 
USA) to index the contents of PubMed. The adopted 
search strategy was Title: ((Diabet* and Retinopathy) or 
(Diabetic Retinopathy)) as the search keyword. This 
yielded 3228 publications. The ‘*’ is a wildcard that can 
take any value. Our search focused on articles published 
during 1993–2013. Our search was performed in Feb 
2014. We included only research articles in the analysis 
and excluded meeting abstracts, case reports, review 
articles as well as letters. 
 
Data Analysis 
We retrieved documents related to main journals in this 
field, articles’ language, the publication year, first author, 
geographical distribution, institutional affiliations and 
citations of the paper by other papers from the ISI and 
analyzed with the analyze function provided by the ISI 
database. Also, we used the Journal Citation Reports 
(available at http://scientific.thomson.com/products/jcr) 
to derive journal’s impact factor. Software for statistical 
analysis in this study was Microsoft Excel 2003 computer 
spreadsheet software (Microsoft; Redmond, WA, USA). 
Analysis of related articles by HistCite software was 
performed considering the topic’s structure, history, and 
document relationships. We imported the bibliography 
derived from the web of science database to HistCite. 
Any articles that cited ≥ 100 were included in 
historiography of the DR research field from 1993 to 
2013 (please refer to Appendix 1). Articles that were 
cited more than 100 times were evaluated by the 
country of affiliation of the first author and publishing 
journal. For identification of recent trends, the citation 
analysis was repeated for articles published from 2010 to 
2013. For the citation analysis, two parameters were 
calculated: the local citation score (LCS) and the global 
citation score (GCS). The LCS lists all papers sorted by 
citation frequency within the local (i.e., the starting 
bibliography). By contrast, the GCS counts citations in the 
whole collection. For the citation burst analysis, the 
hundred keywords that generated the citation bursts 
were extracted, and then the nonspecific and general 
keywords were omitted.
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Figure 1. The Number of Papers Published Annually  
The growth rate of 6.46% in the article numbers was observed.
 
RESULTS 
Annual Publication Number During 1993–2013 
There were 3,228 research articles on DR in the ISI Web 
of Science published during 1993–2013. These papers 
were drafted by 11,591 authors, 2,771 institutions, and 
93 countries. The articles were published in 547 journals 
in 10 languages. Figure 1 demonstrates the growth rate 
(6.46% per year) of publications in this field. 
Citation Profile of Articles 
The total LCS citations were 12,830 times and the GCS 
citations were 62,327 times. The average citation per 
paper (C/P) was 19.31. Table 1 shows the articles that 
were cited ≥ 100. Appendix 1 shows the highly cited 
articles in this field. Figure 2 shows the histogram map of 
20 years of research in this field. Keywords that 
generated citation bursts during this period were as 
follows:  Metabolic control, Onset, Diabetes-mellitus, 
Glycosylated hemoglobin, Fluorescein angiography, 
Fluorophotometry, Neovascular glaucoma, 
Microangiopathy, Microalbuminuria, Glycation, 
Proliferative retinopathy, NIDDM, Proteinuria, 
Photocoagulation, Retinal blood-flow, VEGF, 
Maculopathy, Insulin, Nitric oxide, Screening, 
Telemedicine, Retinal microvascular abnormalities, 
Oxidative stress, Bevacizumab, Vitrectomy, and 
inflammation (Fig. 3).  
 
Subject Analysis and Publisher of Documents 
The most frequent topics of the top 10 highly cited 
papers were translational research (30%) and 
epidemiologic studies (70%) (Table1). 
 
Profiles of Most Influential Authors and Journals 
The highest number of articles was published by Dr. R. 
Klein with 133 articles (Table 2). When analyzed by the 
number of papers in DR, 14 of the top 20 journals were 
ophthalmology journals and the remaining were diabetes 
journals. However, when using the same calculation 
based on the citation number (TLCS), 6 journals were 
diabetes journals, 12 journals were ophthalmology 
journals, and 2 journals were general subject medicine 
journals. When analyzed by the TGCS, highly cited papers 
were published in ophthalmology journals, diabetes 
journals, general medicine journals, neurology journals 
and pathology journals (Table 3). Most DR articles were 
in English (3,058 articles) followed by German (54 
articles), French (47 articles), and Spanish (21 articles). 
Articles were written in a total of 10 languages (English, 
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German, French, Spanish, Portuguese, Russian, Chinese, 
Serbo-Croatian, Slovene, and Turkish). 
Geographical Distribution 
Most of the top 10 Universities and institutions on the 
list are from the United States and Australia. The first 
two institutions are the University of Wisconsin and 
University of Melbourne, based on the number of 
documents, and the University of Wisconsin and Harvard 
University in based on citations (Table 4). 
In general, 93 countries promoted the field of DR by 
publishing articles. The United States, United Kingdom, 
and Japan had the highest number of documents, but the 
United States, United Kingdom, and Australia had the 
highest number of citations to their research papers in 
the field of DR (Table 5). 
 
  
Table 1. Articles With Highest Number of Citations (LCS) 
# Author/ Title / Journal  CITATION 
1 Aiello Lp, Avery Rl, Arrigg Pg, Keyt Ba, Jampel Hd, Et Al. 
Vascular Endothelial Growth-Factor In Ocular Fluid Of Patients With Diabetic-Retinopathy 
And Other Retinal Disorders 
New England Journal Of Medicine. 1994 Dec 1; 331 (22): 1480-1487  
 1,877 
2 Adamis Ap, Miller Jw, Bernal Mt, Damico Dj, Folkman J, Et Al. 
Increased Vascular Endothelial Growth-Factor Levels In The Vitreous Of Eyes With 
Proliferative Diabetic-Retinopathy 
American Journal Of Ophthalmology. 1994 Oct; 118 (4): 445-450  
 745 
3 Shannon H, Duffy H, Dahms W, Mayer L, Brillion D, Et Al. 
Retinopathy And Nephropathy In Patients With Type 1 Diabetes Four Years After A Trial Of 
Intensive Therapy. 
New England Journal Of Medicine. 2000 Feb 10; 342 (6): 381-389 
 622 
4 Dyck Pj, Kratz Km, Karnes Jl, Litchy Wj, Klein R, Et Al. 
The Prevalence By Staged Severity Of Various Types Of Diabetic Neuropathy, Retinopathy, 
And Nephropathy In A Population-Based Cohort - The Rochester Diabetic Neuropathy 
Study 
Neurology. 1993 Apr; 43 (4): 817-824 
 518 
5 Chaturvedi N, Sjolie Ak, Stephenson Jm, Abrahamian H, Keipes M, Et Al. 
Effect Of Lisinopril On Progression Of Retinopathy In Normotensive People With Type 1 
Diabetes 
Lancet. 1998 Jan 3; 351 (9095): 28-31 
 393 
6 Wilkinson Cp, Ferris Fl, Klein Re, Lee Pp, Agardh Cd, Et Al. 
Proposed International Clinical Diabetic Retinopathy And Diabetic Macular Edema Disease 
Severity Scales 
Ophthalmology. 2003 Sep; 110 (9): 1677-1682 
 372 
7 Schrier Rw, Estacio Ro, Esler A, Mehler P 
Effects Of Aggressive Blood Pressure Control In Normotensive Type 2 Diabetic Patients On 
Albuminuria, Retinopathy And Strokes 
Kidney International. 2002 Mar; 61 (3): 1086-1097 
 367 
8 Joussen Am, Poulaki V, Le Ml, Koizumi K, Esser C, Et Al. 
A Central Role For Inflammation In The Pathogenesis Of Diabetic Retinopathy 
Faseb Journal. 2004 Jul; 18 (10): 1450-+ 
 358 
9 Hammes Hp, Du Xl, Edelstein D, Taguchi T, Matsumura T, Et Al. 
Benfotiamine Blocks Three Major Pathways Of Hyperglycemic Damage And Prevents 
Experimental Diabetic Retinopathy 
Nature Medicine. 2003 Mar; 9 (3): 294-299 
 343 
 Med Hypothesis Discov Innov Ophthalmol. 2015; 4(3)  
 
SCIENTOMETRIC ANALYSIS ON DIABETIC RETINOPATHY 85 
10 Miyamoto K, Khosrof S, Bursell Se, Rohan R, Murata T, Et Al. 
Prevention Of Leukostasis And Vascular Leakage In Streptozotocin-Induced Diabetic 
Retinopathy Via Intercellular Adhesion Molecule-1 Inhibition 
Proceedings Of The National Academy Of Sciences Of The United States Of America. 1999 




We analyzed the subject of highly cited papers, divided 
them into broad categories of clinical\translational 
versus basic science research (Appendix 1). Most highly 
cited papers are epidemiologic or translational science 
reports. Despite the enormous impact of DR on the 
quality of life and emotional status of patients, few 
articles among these highly cited papers addressed this 
subject. Highly cited reports were also addressing the 
following topics more frequently: laser photocoagulation 
and angiogenesis. As Appendix 2 shows, there is a recent 
trend toward more translational research such as 
biomarker discovery. Areas such as gene therapy and 
micro-RNA are among the recent hot topics. Citation 
burst analysis showed that certain topics are very 






stress in the pathogenesis of DR. In general, in the field of 
ophthalmology, there was an increase in the proportion 
of articles related to medical retina, compared to other 
subspecialties, between 2005 and 2009. In an analytical 
study of the ophthalmology research papers, case-
control or cohort studies comprised most study designs 
(40.1%), followed by nonanalytic studies (28.7%), basic 
science (24.6%), randomized controlled trials (RCTs) 
(3.3%), review articles (2.6%), and meta-analyses (0.3%) 
(12). However, this was not the trend in diabetes 
retinopathy research. The term “citation analysis” covers 
concepts such as journal impact factor (JIF), the 
immediacy index, and cited and citing half-lives. The 
results of citation analysis should be interpreted 
concurrently with the results of the JIF because ranking 
of research groups on the basis of JIF has little 
correlation to a ranking of the same groups on the basis 
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Table 2. The Most Active Authors in the Field of DR Research 
# Author Recs TLCS TGCS 
1 Klein R 133 1653 6084  
2 Wong Ty 76 595 1868  
3 Klein Bek 69 861 2933  
4 Wang Jj 50 455 1504  
5 Moss Se 44 717 2642  
6 Sharma T 37 163 352  
7 Aiello Lp 35 506 3350  
8 Hammes Hp 35 164 1616  
9 Kowluru Ra 34 276 1063  
10 Raman R 33 121 230  
 
Thus, authors who are frequently cited but choose to 
publish in an appropriate but lower JIF-ranked journal 
would not receive the best evaluation from the 
institutional Journal Citation Report-based assessment of 
an author. Overall, in our study, there was no significant 
correlation between the JIFs and the citation frequency 
of articles. This can result from several factors; for 
example, journals with advance online publication had 
higher impact factors than journals without advance 
online publication. Thus, factors other than the quality of 
papers may affect the citation frequency of a paper (13). 
In a survey of 46 ophthalmology journals to identify the 
most frequently cited articles using the Science Citation 
Index Expanded (1975–2006), the 100 most cited articles 
were published in 13 journals, the utmost articles were in 
the Archives of Ophthalmology (n = 30), followed by 
Ophthalmology (n = 27). American Journal of 
Ophthalmology (n = 11) was in third place. The published 
articles originated from 10 countries, led by the United 
States (n = 86) (14). Laser photocoagulation to treat DR 
was one of the major topics among the 100 most cited 
articles. In addition, we found that the h-index of DR was 
98, which indicates the appreciation of the context of DR 
within vision research. Publications of Dr. Klein, who is 
the most active scientist in the field of DR research, are 
also among the top 100 most cited articles in the field of 
ophthalmology, which shows the importance of this field. 
Our results for the field of citation analysis showed that 
most citation clusters were generated by few countries 
and few journals, mostly from the United States and 
Australian institutions. This fact may be because of the 
overwhelming influence of the United States on 
research. However, it may also be because of a tendency 
for American authors to cite local papers and for authors 
in other parts of the world to publish in and cite 
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Fig.2. Histogram map of 20 years of research in DR 
 
Keywords  Strength  Begin  End  1992 - 2014  
Metabolic control  8.0699  1992  2001  ▃▃▃▃▃▃▃▃▃▃▂▂▂▂▂▂▂▂▂▂▂▂▂  
Onset  7.8749  1992  2001  ▃▃▃▃▃▃▃▃▃▃▂▂▂▂▂▂▂▂▂▂▂▂▂  
Diabetes-mellitus  7.158  1992  1994  ▃▃▃▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂  
Glycosylated hemoglobin  5.8617  1992  1997  ▃▃▃▃▃▃▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂  
Fluorescein angiography  5.6114  1992  1998  ▃▃▃▃▃▃▃▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂  
Fluorophotometry  5.0165  1992  1998  ▃▃▃▃▃▃▃▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂  
Neovascular glaucoma  4.5041  1992  2000  ▃▃▃▃▃▃▃▃▃▂▂▂▂▂▂▂▂▂▂▂▂▂▂  
Microangiopathy  4.4163  1992  2000  ▃▃▃▃▃▃▃▃▃▂▂▂▂▂▂▂▂▂▂▂▂▂▂  
Microalbuminuria  13.4556  1994  2000  ▂▂▃▃▃▃▃▃▃▂▂▂▂▂▂▂▂▂▂▂▂▂▂  
Glycation  3.4028  1994  1995  ▂▂▃▃▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂  
Proliferative retinopathy  5.2867  1995  2001  ▂▂▂▃▃▃▃▃▃▃▂▂▂▂▂▂▂▂▂▂▂▂▂  
NIDDM 12.6527  1996  2001  ▂▂▂▂▃▃▃▃▃▃▂▂▂▂▂▂▂▂▂▂▂▂▂  
Proteinuria  5.6377  1996  2001  ▂▂▂▂▃▃▃▃▃▃▂▂▂▂▂▂▂▂▂▂▂▂▂  
Photocoagulation  3.8159  1996  1996  ▂▂▂▂▃▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂  
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Retinal blood-flow  3.4049  1996  1997  ▂▂▂▂▃▃▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂  
VEGF  4.3345  1997  2003  ▂▂▂▂▂▃▃▃▃▃▃▃▂▂▂▂▂▂▂▂▂▂▂  
Maculopathy  3.5225  1997  2001  ▂▂▂▂▂▃▃▃▃▃▂▂▂▂▂▂▂▂▂▂▂▂▂  
Insulin  6.8506  1998  2002  ▂▂▂▂▂▂▃▃▃▃▃▂▂▂▂▂▂▂▂▂▂▂▂  
Nitric oxide  5.5548  2001  2003  ▂▂▂▂▂▂▂▂▂▃▃▃▂▂▂▂▂▂▂▂▂▂▂  
Screening  6.3987  2002  2004  ▂▂▂▂▂▂▂▂▂▂▃▃▃▂▂▂▂▂▂▂▂▂▂  
Telemedicine  4.4617  2002  2005  ▂▂▂▂▂▂▂▂▂▂▃▃▃▃▂▂▂▂▂▂▂▂▂  
Retinal microvascular abnormalities  3.4268  2006  2007  ▂▂▂▂▂▂▂▂▂▂▂▂▂▂▃▃▂▂▂▂▂▂▂  
Oxidative stress  10.1662  2009  2014  ▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▃▃▃▃▃▃  
Bevacizumab  6.496  2009  2010  ▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▃▃▂▂▂▂  
Vitrectomy  4.0998  2010  2010  ▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▃▂▂▂▂  
Inflammation  11.8843  2011  2014  ▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▂▃▃▃▃  
Figure 3. Keywords with the largest citation burst and the corresponding years 
 
Table 3. Journals with Highest Number of Papers in This Field 
# Journal Records Citation  2 year IF 5 year 
IF 
1 Investigative Ophthalmology & Visual Science 167 4378 3.441 3.730 
2 Diabetes Care 162 4463 7.735 7.555 
3 Diabetic Medicine 124 2380 3.241 3.303 
4 British Journal Of Ophthalmology 115 2845 2.725 3.023 
5 Ophthalmology 103 4349 5.563 5.777 
6 Retina-The Journal Of Retinal And Vitreous Diseases 98 1482 2.825 2.761 
7 Diabetes Research And Clinical Practice 97 898 2.741 2.618 
8 American Journal Of Ophthalmology 89 3275 3.631 4.292 
9 Diabetologia 87 2968 6.487 6.772 
10 Eye 83 1124 1.818 1.883 
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11 Graefes Archive For Clinical And Experimental 
Ophthalmology 
82 1067 1.932 2.037 
12 Archives Of Ophthalmology 81 3787 3.826 4.160 
13 Diabetes 77 4552 7.895 8.611 
14 Journal Of Diabetes And Its Complications 55 649 2.056 2.076 
15 Molecular Vision 52 499 1.987 2.311 
16 Ophthalmologica 48 427 1.412 1.236 
17 Acta Ophthalmologica Scandinavica 47 456 - - 
18 Clinical And Experimental Ophthalmology 45 324 1.964 2.047 
19 Acta Ophthalmologica 43 379 2.345 2.428 
20 Current Eye Research 36 452 1.710 1.702 
 
Table 4. Institutions with highest number of papers 
# Institution Records TLCS TGCS 
1 University  Wisconsin 168 2020 7248 
2 University  Melbourne 106 884 2721 
3 Harvard University  80 938 6029 
4 University  Sydney 75 631 2205 
5 Natl University  Singapore 64 501 1433 
6 Wayne State University  53 331 1584 
7 Johns Hopkins University  43 320 1160 
8 Northeastern Illinois University 39 522 1921 
9 Case Western Reserve University  36 328 2064 
10 Aarhus University  Hospital 31 240 976 
11 The University of Tokyo 31 63 312 
12 Singapore National Eye Center 30 149 345 
13 Joslin Diabetes Center 29 413 2911 
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14 Shanghai Jiao Tong University  29 46 221 
15 Capital Med University  28 94 204 
16 University Heidelberg 28 112 1152 
17 Sankara Nethralaya 25 92 179 
19 University  Oklahoma 25 130 654 
20 St Thomas Hospital 24 301 1102 
 
 
Table 5. Countries With Highest Number of Publications 
in the Field of DR 
# Country Recs TLCS TGCS 
1 USA 837 5682 29687 
2 UK 348 1948 7952 
3 Japan 330 1051 6373 
4 Peoples R China 220 386 1557 
5 Australia 206 1210 4050 
6 Germany 184 736 4974 
7 Italy 123 348 1629 
8 India 115 477 1319 
9 Spain 100 219 1218 
10 Denmark 92 515 2226 
11 France 90 298 1476 
12 Singapore 83 551 1584 
13 Brazil 76 204 837 
14 Sweden 75 318 1591 
15 Turkey 68 132 634 
16 Canada 66 221 1163 
17 South Korea 66 118 517 
 
Factors that influence the number of citations that can 
be obtained by a scientific paper include (1) the merit of 
journal of publication and (2) the number of references 
that citing papers use, which is substantially affected by 
the differences between fields. Also, (3) the number of 
scientists active in the same field or subfield is important 
when there are relatively few colleagues working on the 
same topic. Thus, if for example, more scientists are 
working on the laser treatment of DR, then there would 
be heterogeneity between subfields. This may account 
for the difference in the number of citations between the 
various types of research papers in DR. For example, 
scientists active in more basic fields can obtain different 
numbers of citations than more clinically oriented 
scientists (15). Among the top 100 cited articles, we 
could determine that scientists active in the field of 
translational research and those who were authors on 
epidemiological studies and RCTs could receive 
significantly more citations. Much of the burden of visual 
disorders could be alleviated through at least the three 
routes: prevention and diagnostic screening, medical 
treatment of diagnosed conditions, and rehabilitation 
and support services for those with visual impairment. 
Each year, tens of thousands of articles in these areas are 
published that discuss the medical, policy, and economic 
aspects of visual problems. Despite this excellent and 
growing body of work, several areas of research remain 
virtually nonexistent such as comparing the population 
benefits of investments in medical treatments for people 
with vision-threatening disease, compared to 
rehabilitation and adaptive services for people who have 
previously acquired impairment. To provide better 
guidelines for vision research, five major priorities for 
research were determined by four authorities in A Vision 
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for Horizon 2020. These priorities included neuron–glia 
interaction, gene therapy in retinal diseases, micro-
incision cataract surgery, and femtosecond laser surgery. 
Improving care and care delivery in the Third World 
countries has also been mentioned as a research priority. 
The experts felt that these priority settings may be 
biased since they are significantly different from topics 
set by other authorities (16). The results of our and 
similar studies would help to more accurately determine 
research priorities in the field of DR. In conclusion, this 
report is the first scientometric analysis of the field of DR 
and can be a roadmap for future research policy in this 
important field.  
In conclusion, this report as the first scientometric 
analysis of the field of DR, can be regarded as roadmap 
for future research policy making in this important field. 
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